Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Ambu A/S

Ambu specializes in single-use devices that are designed to improve patient care and safety in medical procedures, self-described as pioneering in endoscopy.

msh id	COM:AMBU
symbol	AMBU-B
name	Ambu A/S
homepage url	https://www.ambu.com
country	DK
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	4.6K
crunchbase url	-
linkedin url	-
founders	-

market cap	5.36B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	41.74K
monthly webtraffic growth	0.77
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.03
growth cost of revenue	0.09
growth depreciation and amortization	-0.01
growth ebitda	0.27
growth ebitda ratio	0.18
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.15
growth gross profit	0.06
growth gross profit ratio	-0.01

AMBU

COM:AMBU

Ambu

Last Close

110.85

22/11 10:20

Market Cap

37.02B

Beta: -

Volume Today

106.61K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	647.27M
cost of revenue	647.27M
depreciation and amortization	50.36M
ebitda	90.88M
ebitda ratio	0.13
eps	0.09
eps diluted	0.09
operating expenses	348.88M
operating income	43.7M
operating income ratio	0.06

accounts receivables	-6.8M
capital expenditure	-47.17M
cash at beginning of period	27.06M
cash at end of period	22.72M
inventory	131.25M
working capital ttm	1.16B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-